Showing results (1-10 of 72) with videos related to
Sort By:
Pageof 8
Journal of Market Access & Health Policy|August 28, 2024
Valuation of Medical Innovation Handling with Uncertainty and RiskMark Nuijten, Stefano CapriJournal of Market Access & Health Policy|December 14, 2020
Pricing of orphan drugs in oncology and rare diseasesMark Nuijten, Stefano CapriJournal of Market Access & Health Policy|June 13, 2022
An integrated valuation model for payer and investorMark Nuijten, Stefano CapriNestle Nutrition Institute Workshop Series|November 7, 2015
Health Economics in Medical Nutrition: An Emerging ScienceMark NuijtenClinical Therapeutics|July 16, 2003
Cost-minimization analysis of pegylated liposomal doxorubicin versus topotecan for the treatment of ovarian cancer in ItalyStefano Capri, Giulio CattaneoCurrent Medical Research and Opinion|July 12, 2005
Cost-effectiveness in Italy of preventive treatment with ramipril in patients at high risk of cardiovascular eventsStefano Capri, Stefano PerliniBMC Health Services Research|January 27, 2017
Cost of breast cancer based on real-world data: a cancer registry study in ItalyStefano Capri, Antonio RussoClinical Therapeutics|May 4, 2010
A health-economic evaluation of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis from the German societal perspectiveMark Nuijten, Thomas MittendorfEuropean Journal of Pharmacology|August 4, 2011
Nutrition economics: an innovative approach to informed public health managementMark Nuijten, Irene Lenoir-WijnkoopBMC Health Services Research|March 13, 2021
The impact of early phase price agreements on prices of orphan drugsMark Nuijten, Philippe Van WilderPageof 8